Disease | intestinal disease |
Comorbidity | C0024299|lymphomas |
Sentences | 2 |
PubMedID- 20712883 | What does seem likely, however, is a risk of developing hepatosplenic t cell lymphomas in children with inflammatory bowel disease (ibd) treated with a combination of azathioprine or 6-mercaptopurine (6-mp), and a monoclonal antibody (mab) directed against tnf (e.g., infliximab or adalimumab) [13]. |
PubMedID- 23332928 | Intestinal gammadelta t-cell lymphomas are most frequently of type ii enteropathy-associated t-cell type. |
Page: 1